|
Volumn 98, Issue 21, 2001, Pages 12168-12173
|
Specific treatment of autoimmunity with recombinant invariant chains in which CLIP is replaced by self-epitopes
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMINO ACID;
CHAPERONE;
EPITOPE;
HYBRID PROTEIN;
MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;
MYELIN BASIC PROTEIN;
PEPTIDE;
RECOMBINANT PROTEIN;
ALLERGIC ENCEPHALOMYELITIS;
ANIMAL CELL;
ANIMAL TISSUE;
ANTIGEN PRESENTING CELL;
ARTICLE;
AUTOIMMUNE DISEASE;
AUTOIMMUNITY;
COMPLEX FORMATION;
CONTROLLED STUDY;
DISEASE SEVERITY;
EXPERIMENTAL MODEL;
FEMALE;
IMMUNOMODULATION;
IN VITRO STUDY;
IN VIVO STUDY;
LYMPHOCYTE PROLIFERATION;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN BINDING;
T LYMPHOCYTE ACTIVATION;
ANIMALS;
ANTIGEN PRESENTATION;
ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE;
AUTOANTIGENS;
AUTOIMMUNITY;
ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL;
EPITOPES, T-LYMPHOCYTE;
FEMALE;
HISTOCOMPATIBILITY ANTIGENS CLASS II;
INJECTIONS, INTRAVENOUS;
LYMPHOCYTE ACTIVATION;
MICE;
MYELIN BASIC PROTEINS;
RECOMBINANT FUSION PROTEINS;
SELF TOLERANCE;
|
EID: 0035834038
PISSN: 00278424
EISSN: None
Source Type: Journal
DOI: 10.1073/pnas.221220998 Document Type: Article |
Times cited : (20)
|
References (21)
|